Micro Interventional Devices Secures Part of Series B Led by Originate Ventures

Micro Interventional Devices, an emerging cardiovascular medical device company, has secured $3.5 million of its expected $5 million Series B financing. The initial tranche was led by Originate Ventures with existing investor, Battelle Ventures also participating in the round. In conjunction with the financing Mike Gausling, managing partner of Originate Ventures, will join the MID board of directors.

North AmericaUSBriefs